氧合过程中给予甲烷可减轻猪24小时静脉-静脉体外膜氧合模型的急性肾损伤
该实验用麻醉小型猪分三组(每组n=6):对照组仅置管不做ECMO;v-v ECMO组行24小时v-v ECMO后观察6小时;v-v ECMO+CH4组经氧合器给予2%甲烷-空气混合气。与v-v ECMO组相比,CH4组ECMO后肾动脉血流更高(244.7±70 vs 96.3±21 mL/min)、平均尿量更多(5.75±1.6 vs 3.25±0.4 mL/h/kg)、组织学损伤评分更低(0.8±0.3 vs 3.3±0.8),尿和血浆NGAL降低,黄嘌呤氧化还原酶与髓过氧化物酶活性及IL-1β、IL-8、亚硝酸盐/硝酸盐水平下降。作者认为甲烷可减轻v-v ECMO相关炎症激活与肾损伤,可能作为减少肾脏并发症的辅助手段。
要点
- 猪v-v ECMO模型中,经氧合器给予2%甲烷-空气混合气24小时,ECMO后肾动脉血流244.7±70 vs 96.3±21 mL/min,高于单纯v-v ECMO组。
- CH4组平均尿量5.75±1.6 vs 3.25±0.4 mL/h/kg,高于v-v ECMO组。
- CH4组肾脏组织学损伤评分0.8±0.3 vs 3.3±0.8,低于v-v ECMO组,同时尿和血浆NGAL降低。
- CH4组黄嘌呤氧化还原酶、髓过氧化物酶活性及IL-1β、IL-8、亚硝酸盐/硝酸盐水平均降低。
- 作者认为CH4可能作为减少v-v ECMO治疗肾脏并发症的有效辅助手段。
适用人群与场景
- 麻醉小型猪,行右股静脉与颈内静脉置管后建立v-v ECMO并维持24小时,随后ECMO后观察6小时。
- 对照组仅置管不做ECMO;v-v ECMO+CH4组经氧合器给予2%甲烷-空气混合气。
处置流程与药物剂量
- v-v ECMO+CH4组经氧合器给予2%甲烷-空气混合气,ECMO维持24小时,随后6小时ECMO后观察。
- 肾损伤评估采用血浆和尿中性粒细胞明胶酶相关脂质运载蛋白水平,并记录尿量。
- 炎症激活评估采用血浆IL-1β和IL-8水平;肾组织分析组织病理学改变、黄嘌呤氧化还原酶和髓过氧化物酶活性及亚硝酸盐/硝酸盐水平。
研究设计与关键结果
- 研究类型为实验性动物研究,麻醉小型猪分三组(每组n=6):对照组、v-v ECMO组、v-v ECMO+CH4组。
- CH4组ECMO后肾动脉血流244.7±70 vs v-v ECMO组96.3±21 mL/min,CH4组更高。
- CH4组平均尿量5.75±1.6 vs v-v ECMO组3.25±0.4 mL/h/kg,CH4组更高。
- CH4组尿和血浆中性粒细胞明胶酶相关脂质运载蛋白水平降低,组织学损伤评分0.8±0.3 vs v-v ECMO组3.3±0.8,CH4组更低。
- CH4组黄嘌呤氧化还原酶和髓过氧化物酶活性降低,炎症介质IL-1β、IL-8及亚硝酸盐/硝酸盐减少。
证据类型、等级与局限
- 证据类型:实验性动物研究(猪v-v ECMO模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为CH4可显著减轻v-v ECMO相关炎症激活与肾损伤,提示CH4可能作为减少v-v ECMO治疗肾脏并发症的有效辅助手段。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Severe respiratory failure often requires veno-venous extracorporeal membrane oxygenation (v-v ECMO) treatment, a procedure frequently associated with acute kidney injury (AKI). Preclinical studies have demonstrated the anti-inflammatory properties of inhaled methane (CH 4 ). This experimental protocol aimed to investigate whether CH 4 gas administration could mitigate the development of AKI in a clinically relevant large animal model of v-v ECMO. Methods: Anesthetized miniature pigs were divided into three groups (n = 6 each). Following cannulation of the right femoral and internal jugular veins, v-v ECMO was initiated and maintained for 24 h, followed by a 6-h post-ECMO observation. The control group underwent cannulation without ECMO, while the v-v ECMO+CH 4 group received a 2% CH 4 -air mixture via the oxygenator. Urine output was recorded, and kidney injury was assessed using plasma and urine neutrophil gelatinase-associated lipocalin levels. Inflammatory activation was evaluated through plasma interleukin-1β (IL-1β) and interleukin-8 (IL-8) levels. Kidney tissue samples were analyzed for histopathological changes, xanthine oxidoreductase and myeloperoxidase activities, and nitrite/nitrate levels. Results: The CH 4 -treated group exhibited significantly higher post-ECMO renal arterial flow (244.7 ± 70 vs. 96.3 ± 21 mL/min) and increased average urine output (5.75 ± 1.6 vs. 3.25 ± 0.4 mL/h/kg) compared to the v-v ECMO group. CH 4 administration reduced urine and plasma neutrophil gelatinase-associated lipocalin levels and demonstrated lower histological damage scores (0.8 ± 0.3 vs. 3.3 ± 0.8). Furthermore, CH 4 treatment decreased xanthine oxidoreductase and myeloperoxidase activities and reduced inflammatory mediators, including IL-1β, IL-8, and nitrite/nitrate. Conclusion: CH 4 admixture significantly mitigates inflammatory activation and renal injury associated with v-v ECMO. These findings suggest that CH 4 may serve as an effective adjunctive means to reduce renal complications of v-v ECMO therapy.
参考来源
- Vida N, Varga Z, Szabó-Biczók A, et al. METHANE ADMINISTRATION DURING OXYGENATION MITIGATES ACUTE KIDNEY INJURY IN A PIG MODEL OF 24-H VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION. Shock. 2025. PMID: 40148266. doi:10.1097/SHK.0000000000002586
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。